The Study to Evaluate the Effect of marma therapy With an injectival drug(DSCB) in the Management of Gridhrasi (Sciatica).
Not Applicable
- Conditions
- Health Condition 1: M543- SciaticaHealth Condition 2: M543- Sciatica
- Registration Number
- CTRI/2022/10/046601
- Lead Sponsor
- Dr Anil Kumar Sharma
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.patient willing for trial.
2.patient of age group above 18 years with radiating pain in unilateral limb.
3.patient with controlled diabetes.
Exclusion Criteria
1. patient not willing for trial or not ready to give consent
2.patient with infectious diseases of spine.
3.patient with infection at the site of DSCB infiltration.
4. patient with malignancy.
5. pregnant and lactating females.
6.patient with hypersensitivity to the drugs.
7.addicted patients such drug abusers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Assessment of duration of pain relief. <br/ ><br>2.Assessment of improvement of the range of movement.Timepoint: 01-02 weeks
- Secondary Outcome Measures
Name Time Method To assess the quality of lifeTimepoint: 03-04 weeks